Jennifer Allport-Anderson hunts for cardiac cures.

Novartis-Harvard team identifies a new type of cell that is key to the disease.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Targeting inflammation to fight cancer is a new approach with a long history.

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Novartis collaborates with the Banner Alzheimer’s Institute to test treatments for preventing Alzheimer’s disease.

Novartis is developing an experimental drug for weight loss.